Insider Transactions in Q1 2021 at Myovant Sciences Ltd. (MYOV)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,000
-4.95%
|
$168,000
$24.17 P/Share
|
|
Mar 19
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.71%
|
$49,000
$7.78 P/Share
|
|
Mar 15
2021
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
30,000
-17.06%
|
$750,000
$25.07 P/Share
|
|
Mar 15
2021
|
Matthew Lang General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+14.57%
|
$210,000
$7.78 P/Share
|
|
Mar 01
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,513
-1.11%
|
$33,286
$22.55 P/Share
|
|
Feb 16
2021
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
750
-0.46%
|
$15,750
$21.4 P/Share
|
|
Feb 16
2021
|
Frank Karbe Principal Fin'l & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+0.45%
|
$3,750
$5.11 P/Share
|
|
Jan 28
2021
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
300
-0.18%
|
$7,200
$24.0 P/Share
|
|
Jan 28
2021
|
Frank Karbe Principal Fin'l & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+0.18%
|
$1,500
$5.11 P/Share
|
|
Jan 15
2021
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
750
-0.46%
|
$15,750
$21.5 P/Share
|
|
Jan 15
2021
|
Frank Karbe Principal Fin'l & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+0.45%
|
$3,750
$5.11 P/Share
|
|
Jan 15
2021
|
David C Marek Principal Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
223,076
+50.0%
|
-
|